Development and validation of a stability‐indicating UPLC method for the determination of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide degradation impurities in their triple‐combination dosage form using factorial design of experiments
2012 ◽
Vol 35
(12)
◽
pp. 1638-1648
◽
Keyword(s):
2016 ◽
Vol 2
(1)
◽
pp. 85-93
2015 ◽
Vol 5
(2)
◽
pp. 91
2014 ◽
Vol 3
(7)
◽
pp. 296-300
◽
2012 ◽
Vol 25
(6)
◽
pp. 559-565
Keyword(s):
2007 ◽
Vol 38
(3)
◽
pp. 143-151